Bliss GVS Pharma Limited has informed the Exchange regarding Notice of Postal Ballot
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has issued a Postal Ballot Notice seeking shareholder approval to appoint Mr. Narsimha Shibroor Kamath (DIN: 00140593) as Managing Director for a period of three years, effective from the date the resolution is passed. Mr. Kamath, who is the current Chief Executive Officer and the Promoter of the company, will be redesignated as 'Managing Director & Chief Executive Officer'. He is 72 years old, which is why his appointment requires approval by way of a Special Resolution. His proposed remuneration includes a basic salary of Rs. 1.25 crore per annum, perquisites of Rs. 63.75 lakh, and other allowances of Rs. 61.25 lakh, with annual increments capped at 20%. E-voting begins on December 31, 2025 and ends on January 29, 2026, with results to be announced by February 2, 2026.
This is a formal elevation of the existing Promoter-CEO to the Managing Director role, providing leadership continuity and stability. Shareholders should note the significant remuneration package and the fact that Mr. Kamath, as Promoter, holds 3.24 crore equity shares, meaning his interests are closely aligned with minority shareholders.